Renal Metabolomics Study and Critical Pathway Validation of Shenkang Injection in the Treatment of Chronic Renal Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renal Metabolomics Study and Critical Pathway Validation of Shenkang Injection in the Treatment of Chronic Renal Failure

Published:2024-02-22 Issue:2 Volume:47 Page:499-508
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Zhou Lin¹²,Wang Xiaohui³,Zhang Yi⁴,Xie Yan⁵,Cui Rui⁶,Xia Jinlan¹,Sun Zhi²

Affiliation:

1. School of Minerals Processing and Bioengineering, Central South University

2. Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University

3. Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University

4. School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine

5. Laboratory of Biomedical Engineering, Henan Luoyang Orthopaedic Hospital (Henan Orthopaedic Hospital)

6. Department of Ultrasonography, The Sixth Affiliated Hospital, Sun Yat-sen University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/2/47_b23-00835/_pdf

Reference25 articles.

1. 1) Ito S, Manabe E, Dai Y, Ishihara M, Tsujino T. Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation. J. Pharmacol. Sci., 148, 172–178 (2022).

2. 2) Zhang W, Li P, Zhou H. Mid-short-term risk factors for chronic renal failure in children with posterior urethral valve. Pediatr. Surg. Int., 38, 1321–1326 (2022).

3. 3) Malik A, Longi F, Naeem A, Clemence JJ, Makkinejad A, Norton E, Wu X, Patel HJ, Deeb GM, Yang B. Outcomes in patients with chronic renal failure on hemodialysis after aortic valve or root replacement. Semin. Thorac. Cardiovasc. Surg., 34, 880–888 (2022).

4. 4) Zhang L, Miao R, Yu T, Wei R, Tian F, Huang Y, Tong X, Zhao L. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: a systematic review and network meta-analysis. Pharmacol. Res., 177, 106111 (2022).

5. 5) Luo LP, Suo P, Ren LL, Liu HJ, Zhang Y, Zhao YY. Shenkang injection and its three anthraquinones ameliorates renal fibrosis by simultaneous targeting IƙB/NF-ƙB and Keap1/Nrf2 signaling pathways. Front. Pharmacol., 12, 800522 (2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3